Wellington Management Group’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding GLUE
BBA
Wellington Management Group's GLUE Position: Q3 2026 in Review
Wellington Management Group increased its Monte Rosa Therapeutics (GLUE) stake by 28% in Q3 2026, buying an estimated $1M and bringing the position to 265,884 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1517.
Wellington Management Group first reported a position in GLUE in Q2 2021 and has held it in 12 quarters since. The position peaked at $5.02M in Q2 2026. 190 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.
- Wellington Management Group held 265,884 shares of Monte Rosa Therapeutics worth $3.17M as of Q3 2026.
- Wellington Management Group bought 58,457 Monte Rosa Therapeutics shares in Q3 2026, an estimated $1M.
- Monte Rosa Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q3 2026, its #1517 holding.
- Wellington Management Group first reported a position in Monte Rosa Therapeutics in Q2 2021 and has held it in 12 quarters since.
- Wellington Management Group's Monte Rosa Therapeutics position peaked at $5.02M in Q2 2026.
- 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.